Inconsistent selection and definition of local and regional study endpoints in breast cancer trials

被引：0
|
作者：
Moossdorff, M. [1 ]
Van Roozendaal, L. M. [1 ]
Schipper, R. [1 ]
Strobbe, L. J. A. [2 ]
Voogd, A. G. [1 ]
Tjan-Heijnen, V. C. G. [1 ]
Smidt, M. L. [1 ]
机构：
[1] Maastricht Univ Med Ctr, Maastricht, Netherlands
[2] Canisius Wilhelmina Hosp, Nijmegen, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1971
引用
收藏
页码：S438 / S438
页数：1
相关论文
共 50 条
  • [1] Inconsistent Selection and Definition of Local and Regional Endpoints in Breast Cancer Trials
    van Roozendaal, Lori
    Moossdorff, Martine
    Schipper, Robert-Jan
    Smidt, Marjolein
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 115 - 116
  • [2] Inconsistent Selection and Definition of Local and Regional Endpoints in Breast Cancer Research
    Moossdorff, M.
    Van Roozendaal, L. M.
    Schipper, R.
    Strobbe, L. J.
    Voogd, A.
    Tjan-Heijnen, V. C.
    Smidt, M. L.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S136 - S136
  • [3] Inconsistent selection and definition of local and regional endpoints in breast cancer research
    Moossdorff, M.
    van Roozendaal, L. M.
    Schipper, R. -J.
    Strobbe, L. J. A.
    Voogd, A. C.
    Tjan-Heijnen, V. C. G.
    Smidt, M. L.
    BRITISH JOURNAL OF SURGERY, 2014, 101 (13) : 1657 - 1665
  • [4] Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholders
    Cui, Wanyuan
    Phillips, Kelly-Anne
    Anderson, Richard A.
    Francis, Prudence A.
    Loi, Sherene
    Loibl, Sibylle
    Partridge, Ann H.
    Keogh, Louise A.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (12): : 5599 - 5612
  • [5] Is there consensus in the definition of endpoints in metastatic breast cancer?
    Saad, E. D.
    Katz, A.
    CANCER RESEARCH, 2009, 69 (02) : 232S - 232S
  • [6] Surrogate endpoints in breast cancer screening trials
    Heindel, Walter
    Weigel, Stefanie
    Hense, Hans-Werner
    LANCET ONCOLOGY, 2022, 23 (08): : E361 - E361
  • [7] Breast Cancer Screening Trials: Endpoints and Overdiagnosis
    Jatoi, Ismail
    Pinsky, Paul F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (09): : 1131 - 1135
  • [8] Guidelines for time-to-event endpoints' definitions in cancer randomized controlled trials (RCTs) for breast cancer - results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
    Gourgou-Bourgade, S.
    Dabakuyo-Yonli, S.
    Cameron, D.
    Cardoso, F.
    Poortmans, P.
    Asselain, B.
    Azria, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S441 - S442
  • [9] Inconsistent Reporting and Definition of Time-to-Event Endpoints in CAR T Clinical Trials: A Review of the Literature and a Call for Harmonization
    Grady, Connor B.
    Li, Yimei
    Maude, Shannon L.
    Hexner, Elizabeth O.
    Frey, Noelle
    Porter, David L.
    Hwang, Wei-Ting
    BLOOD, 2024, 144 : 7805 - 7806
  • [10] Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
    Bilusic, Marijo
    Gulley, James L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (01) : 109 - 117
12345